Inventor · disambiguated record
Tapas Das Gupta
Also filed as: DAS GUPTA TAPAS · DAS GUPTA TAPAS K
47 granted patents·7 pending applications·404 citations·filing 2002–2023
98Inventor score
Top patents by PatentIndex Score
54 records- 0198US8017749B2Compositions and methods to treat cancer with cupredoxins and CpG rich DNAUNIV ILLINOIS·Filed 2007·Granted Sep 13, 2011·36 cites·15 claims
- 0297US7691383B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2005·Granted Apr 6, 2010·41 cites·32 claims
- 0396US7338766B2Compositions and methods for treating malaria with cupredoxin and cytochromeUNIV ILLINOIS·Filed 2006·Granted Mar 4, 2008·40 cites·8 claims
- 0496US7301010B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2006·Granted Nov 27, 2007·33 cites·23 claims
- 0595US7381701B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxinsUNIV ILLINOIS·Filed 2006·Granted Jun 3, 2008·24 cites·5 claims
- 0694US8530635B2Cupredoxin derived transport agents and methods of use thereofCHAKRABARTY ANANDA·Filed 2012·Granted Sep 10, 2013·10 cites·36 claims
- 0794US8232244B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2008·Granted Jul 31, 2012·15 cites·46 claims
- 0894US7807183B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2006·Granted Oct 5, 2010·23 cites·22 claims
- 0993US8206685B2Cupredoxin derived transport agents and methods of use thereofCHAKRABARTY ANANDA·Filed 2010·Granted Jun 26, 2012·9 cites·5 claims
- 1092US7511117B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2007·Granted Mar 31, 2009·16 cites·7 claims
- 1191US7556810B2Compositions and methods to control angiogenesis with cupredoxinsUNIV ILLINOIS·Filed 2006·Granted Jul 7, 2009·16 cites·5 claims
- 1290US8227402B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2009·Granted Jul 24, 2012·7 cites·15 claims
- 1390US7084105B2Cytotoxic factors for modulating cell deathUNIV ILLINOIS·Filed 2002·Granted Aug 1, 2006·33 cites·23 claims
- 1489US7740857B2Compositions and methods for treating malaria with cupredoxin and cytochromeUNIV ILLINOIS·Filed 2008·Granted Jun 22, 2010·7 cites·8 claims
- 1588US10117905B2Compositions and methods to prevent cancer with cupredoxinsUNIV ILLINOIS·Filed 2015·Granted Nov 6, 2018·2 cites·11 claims
- 1688US9161989B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2013·Granted Oct 20, 2015·4 cites·11 claims
- 1785US10058585B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereofUNIV ILLINOIS·Filed 2015·Granted Aug 28, 2018·3 cites·8 claims
- 1884US9969781B2Compositions and methods to treat cancer with CpG rich DNA and cupredoxinsDAS GUPTA TAPAS·Filed 2011·Granted May 15, 2018·2 cites·8 claims
- 1984US9309292B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2013·Granted Apr 12, 2016·4 cites·19 claims
- 2084US9107881B2Compositions and methods to control angiogenesis with cupredoxinsUNIV ILLINOIS·Filed 2013·Granted Aug 18, 2015·5 cites·32 claims
- 2184US8545812B2Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereofHONG CHANG SOO·Filed 2012·Granted Oct 1, 2013·6 cites·16 claims
- 2284US7888468B2Cytotoxic factors for modulating cell deathUNIV ILLINOIS·Filed 2006·Granted Feb 15, 2011·6 cites·8 claims
- 2383US8158574B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2008·Granted Apr 17, 2012·4 cites·8 claims
- 2482US9096663B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereofCHAUDHARI ANITA·Filed 2008·Granted Aug 4, 2015·4 cites·5 claims
- 2582US8623816B2Compositions and methods for treating malaria with cupredoxin and cytochromeCHAKRABARTY ANANDA·Filed 2007·Granted Jan 7, 2014·3 cites·2 claims
- 2682US7491394B2Cytotoxic factors for modulating cell deathUNIV ILLINOIS·Filed 2003·Granted Feb 17, 2009·14 cites·3 claims
- 2781US10590177B2Modifications of cupredoxin derived peptidesUNIV ILLINOIS·Filed 2018·Granted Mar 17, 2020·2 cites·5 claims
- 2881US10351605B2Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathwaysTHE BOARD OF TRUSTEE OF THE UNIV OF ILLINOIS·Filed 2017·Granted Jul 16, 2019·2 cites·10 claims
- 2981US10239920B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2015·Granted Mar 26, 2019·2 cites·10 claims
- 3081US9134298B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2012·Granted Sep 15, 2015·2 cites·9 claims
- 3180US8372962B2Compositions and methods to control angiogenesis with cupredoxinsUNIV ILLINOIS·Filed 2012·Granted Feb 12, 2013·3 cites·2 claims
- 3279US10196428B2Modification of cupredoxin derived peptidesUNIV ILLINOIS·Filed 2016·Granted Feb 5, 2019·2 cites·6 claims
- 3379US10086037B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2012·Granted Oct 2, 2018·2 cites·11 claims
- 3479US9957304B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxinsCHAKRABARTY ANANDA·Filed 2008·Granted May 1, 2018·2 cites·8 claims
- 3578US8188251B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofHONG CHANG SOO·Filed 2010·Granted May 29, 2012·3 cites·6 claims
- 3677US10675326B2Compositions comprising cupredoxins for treating cancerUNIV ILLINOIS·Filed 2017·Granted Jun 9, 2020·2 cites·5 claims
- 3777US10005821B2Modifications of cupredoxin derived peptides and methods of use thereofDAS GUPTA TAPAS·Filed 2007·Granted Jun 26, 2018·2 cites·50 claims
- 3876US7795410B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2009·Granted Sep 14, 2010·3 cites·17 claims
- 3975US10421801B2Cytotoxic factors for modulating cell deathUNIV ILLINOIS·Filed 2013·Granted Sep 24, 2019·2 cites·5 claims
- 4075US8124055B2Compositions and methods to control angiogenesis with cupredoxinsMEHTA RAJESHWARI R·Filed 2009·Granted Feb 28, 2012·3 cites·14 claims
- 4172US9434770B2Modified cupredoxin derived peptidesDAS GUPTA TAPAS K·Filed 2009·Granted Sep 6, 2016·2 cites·2 claims
- 4269US9598470B2Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathwaysBEATTIE CRAIG W·Filed 2009·Granted Mar 21, 2017·0 cites·3 claims
- 4368US10266868B2Compositions for treating HIV infection with cupredoxin and cytochrome CCHAKRABARTY ANANDA·Filed 2010·Granted Apr 23, 2019·1 cites·7 claims
- 4467US11046733B2Compositions and methods to treat cancer with CpG rich DNA and cupredoxinsUNIV ILLINOIS·Filed 2017·Granted Jun 29, 2021·0 cites·5 claims
- 4565US2025179126A1A novel peptide from a photosynthetic bacerium directly targets mitochondria to trigger apoptosis in advanced prostate cancer cellsUNIV ILLINOIS·Filed 2023·Application pending·0 cites
- 4662US9968685B2Methods to treat cancer with cupredoxinsTAYLOR BRAD N·Filed 2008·Granted May 15, 2018·2 cites·8 claims
- 4756US10072049B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2016·Granted Sep 11, 2018·0 cites·8 claims
- 4856US2025302306A1Tumor targeting probe for image guided surgical methodsUNIV ILLINOIS·Filed 2022·Application pending·0 cites
- 4953US10266573B2Cytotoxic factors for modulating cell deathCHAKRABARTY ANANDA M·Filed 2008·Granted Apr 23, 2019·0 cites·6 claims
- 5051US2009208476A1Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxinsDAS GUPTA TAPAS·Filed 2008·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tapas Das Gupta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →